查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678668

全球製藥契約製造市場：市場規模、佔有率、趨勢分析（按產品、藥品、服務、業務規模、工作流程、應用、最終用途、公司規模、地區）、細分市場預測（2025-2030 年）

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Drug, By Service, By Scale of Operation, By Workflow, By Application, By End Use, By Company, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

醫藥契約製造市場的成長與趨勢：

根據Grand View Research, Inc.的新報告，到2030年全球醫藥契約製造市場規模預計將達2,245.1億美元。

預計 2025 年至 2030 年期間，市場複合年成長率為 9.84%。該市場的成長機會源於為製藥公司提供的優勢，例如成本效益、透過契約製造設施簡化生產的能力以及專注於核心競爭力的機會。此外，對生技藥品、生物相似藥、高活性藥物成分 (HPAPI) 和個人化醫療的需求不斷成長，正在推動市場的發展。

製藥公司大力推動新產品創新，導致對臨床試驗、包裝和法規合規性的受託製造廠商(CMO) 服務的需求增加。跨 CMO 的技術整合，例如連續製造、自動化和人工智慧驅動的製程最佳化，正在進一步加速製藥製造。這些創新提高了效率、消除了浪費並提高了產品品質和標準。

由於 CMO 供應商在幫助公司滿足 FDA、EMA 和 ICH 的監管要求方面發揮關鍵作用，預計製藥契約製造製造業將在預測期內繼續成長。此外，對品牌學名藥的需求不斷成長也極大地促進了製藥契約製造製造業的擴張。隨著各種學名藥的專利到期，製藥公司正在開發新的學名藥來滿足這一需求。因此，許多製藥公司依賴CMO服務來有效率、有效地滿足其市場需求。

此外，監管是製藥業的關鍵因素之一，推動了對製藥契約製造的需求。 FDA 在確保市場上藥品的安全性和有效性方面發揮著至關重要的作用。同樣，策略夥伴關係和加速產品發布也在推動市場成長。例如，2024 年 12 月，Lonza 提到擴大其口服生物製藥服務產品，以支持創新膠囊公司的獨特開發和製造需求。該產品的推出將使患者能夠探索創新的給藥解決方案，以減輕生物有效性的挑戰。

醫藥契約製造市場：分析概述

  • 2024 年的市場佔有率主要由 API 製造領域佔據，佔 70.68%。該領域的成長可歸因於 HPAPI 產量的增加、對持續 API 製造的需求的不斷成長、FDA 市場批准的不斷擴大以及新產品的推出。
  • 這是因為對於學名藥、特殊藥物和 HPAPI 的需求不斷增加，製藥創新不斷增加，以及對 CMO 的效率、擴充性和法規遵從性的要求不斷提高，這些都進一步推動了市場成長。
  • 慢性病的增加、專利到期數量的增加以及對具成本效益藥品的需求不斷成長，將導致學名藥領域在 2024 年佔據市場主導地位。
  • 根據業務規模，批量配方部分佔據了市場主導地位。到2024年，這一比例將達到88.88%，這得益於批量生產和降低營運成本的關鍵支援等多種優勢。
  • 2024 年，商業領域佔據了市場主導地位。該領域的成長歸因於各種有助於治療疾病的產品的不斷推出。
  • 根據應用，腫瘤學預計將在 2024 年佔據最大的市場佔有率。該細分市場受到癌症發病率增加和新藥需求的推動。
  • 根據最終用途，製藥公司部門在 2024 年佔據最大的市場佔有率。製藥公司正在轉向契約製造以降低成本、提高擴充性並縮短時間。 CMO 提供原料藥合成、配方和法規遵循的專業知識。外包還使您能夠獲得先進的技術、靈活的生產能力和最佳化的全球供應鏈。
  • 2024 年，小型企業將因員工實力、設備和創業投資資金的增加而佔據市場主導地位。
  • 預計亞太地區在預測期內的成長率最快，複合年成長率為 10.80%。由於日本、中國和印度等國家的製藥公司和受託製造廠商數量不斷增加，亞太地區在預測期內可能會快速成長。此外，與美國相比，該地區擁有成本較低的熟練勞動力，這也是推動市場成長的因素。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章：醫藥契約製造市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 醫藥契約製造市場：分析工具
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章 醫藥契約製造市場：按服務分類的估計和趨勢分析

  • 醫藥契約製造市場，依服務：細分儀表板
  • 醫藥契約製造市場（按服務）波動分析
  • 依服務分類（2018-2030 年）
  • API 製造
  • 成品藥製造
    • 口服固態
    • 液體
    • 話題
    • 其他
  • 包裝服務

第 5 章：醫藥契約製造市場：按產品分類的估計和趨勢分析

  • 醫藥契約製造市場，依產品：細分儀表板
  • 醫藥契約製造市場（依產品分類）：波動分析
  • 按產品（2018 - 2030 年）
  • 小分子
  • 生物製藥
    • 單株抗體
    • 疫苗
    • 重組蛋白
    • 其他

第6章 醫藥契約製造市場：按藥物分類的估計和趨勢分析

  • 藥品契約製造市場（按藥品）：細分儀表板
  • 藥品契約製造市場（按藥品）：波動分析
  • 按藥物分類（2018 - 2030 年）
  • 非專利的
  • 品牌

第7章 醫藥契約製造市場：依業務規模估計及趨勢分析

  • 醫藥契約製造市場（按業務規模）：細分儀表板
  • 醫藥契約製造市場依業務規模分類：波動分析
  • 依業務規模（2018-2030 年）
  • 批次
  • 連續的

第 8 章：醫藥契約製造市場：按工作流程進行的估計和趨勢分析

  • 醫藥契約製造市場，依工作流程：細分儀表板
  • 醫藥契約製造市場（按工作流程）：變化分析
  • 按工作流程（2018-2030）
  • 臨床
    • 臨床市場（2018-2030）
  • 商業
    • 商業市場（2018-2030）

第 9 章：醫藥契約製造市場：按應用進行的估計和趨勢分析

  • 醫藥契約製造市場，按應用：細分儀表板
  • 醫藥契約製造市場應用：波動分析
  • 按應用分類（2018-2030）
  • 腫瘤學
    • 腫瘤學市場（2018-2030）
  • 感染疾病
    • 感染疾病市場（2018-2030）
  • 神經系統疾病
    • 神經系統疾病市場（2018-2030）
  • 心血管疾病
    • 心血管疾病市場（2018-2030）
  • 代謝紊亂
    • 代謝紊亂市場（2018-2030）
  • 自體免疫疾病
    • 自體免疫疾病市場（2018-2030）
  • 呼吸系統疾病
    • 呼吸系統疾病市場（2018-2030）
  • 眼科
    • 眼科市場（2018-2030）
  • 消化系統疾病
    • 消化系統疾病市場（2018-2030）
  • 荷爾蒙失調
    • 荷爾蒙失調市場（2018-2030）
  • 血液系統疾病
    • 血液學市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第 10 章：醫藥契約製造市場：按最終用途進行的估計和趨勢分析

  • 醫藥契約製造市場，依最終用途：細分儀表板
  • 按最終用途分類的醫藥契約製造市場：差異分析
  • 依最終用途分類（2018-2030 年）
  • 製藥公司
    • 醫藥市場（2018-2030）
  • 生技公司
    • 生技公司市場（2018-2030）

第 11 章 醫藥契約製造市場：依公司規模估計與趨勢分析

  • 醫藥契約製造市場（依公司規模）：細分儀表板
  • 醫藥契約製造市場（依公司規模）波動分析
  • 按公司規模（2018-2030 年）
  • 小型企業
    • 小型企業市場（2018-2030）
  • 中型企業
    • 中型企業市場（2018-2030）
  • 大型企業
    • 大型企業市場（2018-2030）

第 12 章 醫藥契約製造市場：按地區分類的估計和趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第13章 競爭格局

  • 市場參與企業分類
  • 公司市場佔有率分析（2023/24）
  • 公司簡介
    • AbbVie Contract Manufacturing
    • Almac Group
    • Boehringer Ingelheim BioXcellence
    • Catalent
    • Dr. Reddy's Laboratories
    • Fareva
    • Fujifilm Diosynth Biotechnologies
    • Jubilant HollisterStier
    • Lonza Group
    • Patheon（Thermo Fisher Scientific）
    • Pfizer CentreOne
    • Prakruti Life Science
    • Recipharm
    • Samsung Biologics
    • Siegfried Holding AG
    • Vetter Pharma
    • WuXi AppTec
Product Code: GVR-4-68040-520-6

Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global pharmaceutical contract manufacturing market size is expected to reach USD 224.51 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030. Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.

The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.

The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.

In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies' unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.

Pharmaceutical Contract Manufacturing Market Report Highlights:

  • The API manufacturing segment dominated the market with a share of 70.68% in 2024. Growth in the segment can be attributed to increasing HPAPI production, rising demand for continuous API manufacturing, growing FDA approval for the market, and the launch of new products.
  • Based on product, the small molecule segment held the largest market share in 2024, which is attributed to the increasing demand for generics, specialty drugs, and HPAPIs, and growing innovations of drugs have enhanced the requirement for CMO's efficiency, scalability, and regulatory compliance further driving the market growth.
  • The generics segment dominated the market in 2024 owing to the increasing prevalence of chronic diseases, growing patent expirations, and rising demand for cost-efficient drugs.
  • Based on scale of operation, the batch segment dominated the market. It accounted for 88.88% in 2024, attributing to various benefits such as batch production and major support for saving operational costs.
  • The commercial segment dominated the market in 2024. Growth in this segment can be attributed to the increasing launch of various products that help treat diseases.
  • The oncology segment held the largest market share in 2024 based on application. This segment is driven by increasing cancer incidences and new pharmaceutical drug requirements.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. Pharmaceutical companies utilize contract manufacturing to lower costs, increase scalability, and speed up time-to-market. CMOs offer expertise in API synthesis, formulation, and regulatory compliance. In addition, outsourcing provides access to advanced technologies, flexible production capacity, and optimized global supply chains.
  • The small company size segment dominated the market in 2024 due to increasing employee strengths, facilities, and venture funding.
  • Asia Pacific is expected to register the fastest growth rate of 10.80% CAGR over the forecast period. Due to the rising number of pharmaceutical companies & contract manufacturing organizations in countries like Japan, China, and India, Asia Pacific will likely witness rapid growth over the estimated time. Furthermore, the availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Drug
    • 1.2.4. Scale of Operation
    • 1.2.5. Workflow
    • 1.2.6. Application
    • 1.2.7. End Use
    • 1.2.8. Company Size
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Advancements
  • 3.4. Clinical trials volume analysis (2024)
  • 3.5. Pharmaceutical Contract Manufacturing Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's Five Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Contract Manufacturing Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Contract Manufacturing Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.4. API Manufacturing
    • 4.4.1. API Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Finished Drug Product Manufacturing
    • 4.5.1. Finished Drug Product Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Oral Solids
      • 4.5.2.1. Oral Solids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Liquids
      • 4.5.3.1. Liquids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Topical
      • 4.5.4.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Packaging Services
    • 4.6.1. Packaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Pharmaceutical Contract Manufacturing Market, By Product: Segment Dashboard
  • 5.2. Pharmaceutical Contract Manufacturing Market, By Product: Movement Analysis
  • 5.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030
  • 5.4. Small Molecule
    • 5.4.1. Small Molecule Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biologics
    • 5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Monoclonal Antibodies
      • 5.5.2.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Vaccines
      • 5.5.3.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Recombinant Proteins
      • 5.5.4.1. Recombinant Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis

  • 6.1. Pharmaceutical Contract Manufacturing Market, By Drug: Segment Dashboard
  • 6.2. Pharmaceutical Contract Manufacturing Market, By Drug: Movement Analysis
  • 6.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Drug, 2018 - 2030
  • 6.4. Generics
    • 6.4.1. Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Branded
    • 6.5.1. Branded Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

  • 7.1. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
  • 7.2. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Movement Analysis
  • 7.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
  • 7.4. Batch
    • 7.4.1. Batch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Continuous
    • 7.5.1. Continuous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis

  • 8.1. Pharmaceutical Contract Manufacturing Market, By Workflow: Segment Dashboard
  • 8.2. Pharmaceutical Contract Manufacturing Market, By Workflow: Movement Analysis
  • 8.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Workflow, 2018 - 2030
  • 8.4. Clinical
    • 8.4.1. Clinical Market, 2018 to 2030, (USD Million)
  • 8.5. Commercial
    • 8.5.1. Commercial Market, 2018 to 2030, (USD Million)

Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis

  • 9.1. Pharmaceutical Contract Manufacturing Market, By Application: Segment Dashboard
  • 9.2. Pharmaceutical Contract Manufacturing Market, By Application: Movement Analysis
  • 9.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Application, 2018 - 2030
  • 9.4. Oncology
    • 9.4.1. Oncology Market, 2018 to 2030, (USD Million)
  • 9.5. Infectious Diseases
    • 9.5.1. Infectious Diseases Market, 2018 to 2030, (USD Million)
  • 9.6. Neurological Disorders
    • 9.6.1. Neurological Disorders Market, 2018 to 2030, (USD Million)
  • 9.7. Cardiovascular Disease
    • 9.7.1. Cardiovascular Disease Market, 2018 to 2030, (USD Million)
  • 9.8. Metabolic Disorders
    • 9.8.1. Metabolic Disorders Market, 2018 to 2030, (USD Million)
  • 9.9. Autoimmune Diseases
    • 9.9.1. Autoimmune Diseases Market, 2018 to 2030, (USD Million)
  • 9.10. Respiratory Diseases
    • 9.10.1. Respiratory Diseases Market, 2018 to 2030, (USD Million)
  • 9.11. Ophthalmology
    • 9.11.1. Ophthalmology Market, 2018 to 2030, (USD Million)
  • 9.12. Gastrointestinal Disorders
    • 9.12.1. Gastrointestinal Disorders Market, 2018 to 2030, (USD Million)
  • 9.13. Hormonal Disorders
    • 9.13.1. Hormonal Disorders Market, 2018 to 2030, (USD Million)
  • 9.14. Hematological Disorders
    • 9.14.1. Hematological Disorders Market, 2018 to 2030, (USD Million)
  • 9.15. Others
    • 9.15.1. Others Market, 2018 to 2030, (USD Million)

Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 10.1. Pharmaceutical Contract Manufacturing Market, By End Use: Segment Dashboard
  • 10.2. Pharmaceutical Contract Manufacturing Market, By End Use: Movement Analysis
  • 10.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 10.4. Pharmaceutical Companies
    • 10.4.1. Pharmaceutical Companies Market, 2018 to 2030, (USD Million)
  • 10.5. Biotechnology Companies
    • 10.5.1. Biotechnology Companies Market, 2018 to 2030, (USD Million)

Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis

  • 11.1. Pharmaceutical Contract Manufacturing Market, By Company Size: Segment Dashboard
  • 11.2. Pharmaceutical Contract Manufacturing Market, By Company Size: Movement Analysis
  • 11.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Company Size, 2018 - 2030
  • 11.4. Small
    • 11.4.1. Small Market, 2018 to 2030, (USD Million)
  • 11.5. Medium
    • 11.5.1. Medium Market, 2018 to 2030, (USD Million)
  • 11.6. Large
    • 11.6.1. Large Market, 2018 to 2030, (USD Million)

Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 12.1. Regional Market Share Analysis, 2024 & 2030
  • 12.2. Regional Market Dashboard
  • 12.3. Global Regional Market Snapshot
  • 12.4. North America
    • 12.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.2. U.S
      • 12.4.2.1. Key Country Dynamics
      • 12.4.2.2. Competitive Scenario
      • 12.4.2.3. Regulatory Framework
      • 12.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.3. Canada
      • 12.4.3.1. Key Country Dynamics
      • 12.4.3.2. Competitive Scenario
      • 12.4.3.3. Regulatory Framework
      • 12.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.4. Mexico
      • 12.4.4.1. Key Country Dynamics
      • 12.4.4.2. Competitive Scenario
      • 12.4.4.3. Regulatory Framework
      • 12.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5. Europe
    • 12.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.2. UK
      • 12.5.2.1. Key Country Dynamics
      • 12.5.2.2. Competitive Scenario
      • 12.5.2.3. Regulatory Framework
      • 12.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.3. Germany
      • 12.5.3.1. Key Country Dynamics
      • 12.5.3.2. Competitive Scenario
      • 12.5.3.3. Regulatory Framework
      • 12.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.4. France
      • 12.5.4.1. Key Country Dynamics
      • 12.5.4.2. Competitive Scenario
      • 12.5.4.3. Regulatory Framework
      • 12.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.5. Italy
      • 12.5.5.1. Key Country Dynamics
      • 12.5.5.2. Competitive Scenario
      • 12.5.5.3. Regulatory Framework
      • 12.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.6. Spain
      • 12.5.6.1. Key Country Dynamics
      • 12.5.6.2. Competitive Scenario
      • 12.5.6.3. Regulatory Framework
      • 12.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.7. Denmark
      • 12.5.7.1. Key Country Dynamics
      • 12.5.7.2. Competitive Scenario
      • 12.5.7.3. Regulatory Framework
      • 12.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.8. Sweden
      • 12.5.8.1. Key Country Dynamics
      • 12.5.8.2. Competitive Scenario
      • 12.5.8.3. Regulatory Framework
      • 12.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.9. Norway
      • 12.5.9.1. Key Country Dynamics
      • 12.5.9.2. Competitive Scenario
      • 12.5.9.3. Regulatory Framework
      • 12.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6. Asia Pacific
    • 12.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.2. Japan
      • 12.6.2.1. Key Country Dynamics
      • 12.6.2.2. Competitive Scenario
      • 12.6.2.3. Regulatory Framework
      • 12.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.3. China
      • 12.6.3.1. Key Country Dynamics
      • 12.6.3.2. Competitive Scenario
      • 12.6.3.3. Regulatory Framework
      • 12.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.4. India
      • 12.6.4.1. Key Country Dynamics
      • 12.6.4.2. Competitive Scenario
      • 12.6.4.3. Regulatory Framework
      • 12.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.5. Thailand
      • 12.6.5.1. Key Country Dynamics
      • 12.6.5.2. Competitive Scenario
      • 12.6.5.3. Regulatory Framework
      • 12.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.6. South Korea
      • 12.6.6.1. Key Country Dynamics
      • 12.6.6.2. Competitive Scenario
      • 12.6.6.3. Regulatory Framework
      • 12.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.7. Australia
      • 12.6.7.1. Key Country Dynamics
      • 12.6.7.2. Competitive Scenario
      • 12.6.7.3. Regulatory Framework
      • 12.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.7. Latin America
    • 12.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.7.2. Brazil
      • 12.7.2.1. Key Country Dynamics
      • 12.7.2.2. Competitive Scenario
      • 12.7.2.3. Regulatory Framework
      • 12.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.7.3. Argentina
      • 12.7.3.1. Key Country Dynamics
      • 12.7.3.2. Competitive Scenario
      • 12.7.3.3. Regulatory Framework
      • 12.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8. MEA
    • 12.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.2. South Africa
      • 12.8.2.1. Key Country Dynamics
      • 12.8.2.2. Competitive Scenario
      • 12.8.2.3. Regulatory Framework
      • 12.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.3. Saudi Arabia
      • 12.8.3.1. Key Country Dynamics
      • 12.8.3.2. Competitive Scenario
      • 12.8.3.3. Regulatory Framework
      • 12.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.4. UAE
      • 12.8.4.1. Key Country Dynamics
      • 12.8.4.2. Competitive Scenario
      • 12.8.4.3. Regulatory Framework
      • 12.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.5. Kuwait
      • 12.8.5.1. Key Country Dynamics
      • 12.8.5.2. Competitive Scenario
      • 12.8.5.3. Regulatory Framework
      • 12.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 13. Competitive Landscape

  • 13.1. Market Participant Categorization
  • 13.2. Company Market Share Analysis, 2023/24
  • 13.3. Company Profiles
    • 13.3.1. AbbVie Contract Manufacturing
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Financial Performance
      • 13.3.1.3. Service Benchmarking
      • 13.3.1.4. Strategic Initiatives
    • 13.3.2. Almac Group
      • 13.3.2.1. Company Overview
      • 13.3.2.2. Financial Performance
      • 13.3.2.3. Service Benchmarking
      • 13.3.2.4. Strategic Initiatives
    • 13.3.3. Boehringer Ingelheim BioXcellence
      • 13.3.3.1. Company Overview
      • 13.3.3.2. Financial Performance
      • 13.3.3.3. Service Benchmarking
      • 13.3.3.4. Strategic Initiatives
    • 13.3.4. Catalent
      • 13.3.4.1. Company Overview
      • 13.3.4.2. Financial Performance
      • 13.3.4.3. Service Benchmarking
      • 13.3.4.4. Strategic Initiatives
    • 13.3.5. Dr. Reddy's Laboratories
      • 13.3.5.1. Company Overview
      • 13.3.5.2. Financial Performance
      • 13.3.5.3. Service Benchmarking
      • 13.3.5.4. Strategic Initiatives
    • 13.3.6. Fareva
      • 13.3.6.1. Company Overview
      • 13.3.6.2. Financial Performance
      • 13.3.6.3. Service Benchmarking
      • 13.3.6.4. Strategic Initiatives
    • 13.3.7. Fujifilm Diosynth Biotechnologies
      • 13.3.7.1. Company Overview
      • 13.3.7.2. Financial Performance
      • 13.3.7.3. Service Benchmarking
      • 13.3.7.4. Strategic Initiatives
    • 13.3.8. Jubilant HollisterStier
      • 13.3.8.1. Company Overview
      • 13.3.8.2. Financial Performance
      • 13.3.8.3. Service Benchmarking
      • 13.3.8.4. Strategic Initiatives
    • 13.3.9. Lonza Group
      • 13.3.9.1. Company Overview
      • 13.3.9.2. Financial Performance
      • 13.3.9.3. Service Benchmarking
      • 13.3.9.4. Strategic Initiatives
    • 13.3.10. Patheon (Thermo Fisher Scientific)
      • 13.3.10.1. Company Overview
      • 13.3.10.2. Financial Performance
      • 13.3.10.3. Service Benchmarking
      • 13.3.10.4. Strategic Initiatives
    • 13.3.11. Pfizer CentreOne
      • 13.3.11.1. Company Overview
      • 13.3.11.2. Financial Performance
      • 13.3.11.3. Service Benchmarking
      • 13.3.11.4. Strategic Initiatives
    • 13.3.12. Prakruti Life Science
      • 13.3.12.1. Company Overview
      • 13.3.12.2. Financial Performance
      • 13.3.12.3. Service Benchmarking
      • 13.3.12.4. Strategic Initiatives
    • 13.3.13. Recipharm
      • 13.3.13.1. Company Overview
      • 13.3.13.2. Financial Performance
      • 13.3.13.3. Service Benchmarking
      • 13.3.13.4. Strategic Initiatives
    • 13.3.14. Samsung Biologics
      • 13.3.14.1. Company Overview
      • 13.3.14.2. Financial Performance
      • 13.3.14.3. Service Benchmarking
      • 13.3.14.4. Strategic Initiatives
    • 13.3.15. Siegfried Holding AG
      • 13.3.15.1. Company Overview
      • 13.3.15.2. Financial Performance
      • 13.3.15.3. Service Benchmarking
      • 13.3.15.4. Strategic Initiatives
    • 13.3.16. Vetter Pharma
      • 13.3.16.1. Company Overview
      • 13.3.16.2. Financial Performance
      • 13.3.16.3. Service Benchmarking
      • 13.3.16.4. Strategic Initiatives
    • 13.3.17. WuXi AppTec
      • 13.3.17.1. Company Overview
      • 13.3.17.2. Financial Performance
      • 13.3.17.3. Service Benchmarking
      • 13.3.17.4. Strategic Initiatives

List of Tables

  • Table. 1 List of Secondary Sources
  • Table. 2 List of Abbreviations
  • Table. 3 Global Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 4 Global Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 5 Global Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 6 Global Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 7 Global Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 8 Global Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 9 Global Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 10 Global Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 11 North America Pharmaceutical Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table. 12 North America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 13 North America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 14 North America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 15 North America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 16 North America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 17 North America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 18 North America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 19 North America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 20 U.S. Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 21 U.S. Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 22 U.S. Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 23 U.S. Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 24 U.S. Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 25 U.S. Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 26 U.S. Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 27 U.S. Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 28 Canada Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 29 Canada Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 30 Canada Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 31 Canada Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 32 Canada Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 33 Canada Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 34 Canada Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 35 Canada Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 36 Mexico Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 37 Mexico Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 38 Mexico Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 39 Mexico Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 40 Mexico Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 41 Mexico Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 42 Mexico Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 43 Mexico Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 44 Europe Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 45 Europe Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 46 Europe Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 47 Europe Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 48 Europe Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 49 Europe Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 50 Europe Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 51 Europe Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 52 Europe Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 53 UK Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 54 UK Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 55 UK Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 56 UK Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 57 UK Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 58 UK Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 59 UK Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 60 UK Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 61 Germany Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 62 Germany Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 63 Germany Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 64 Germany Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 65 Germany Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 66 Germany Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 67 Germany Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 68 Germany Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 69 France Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 70 France Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 71 France Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 72 France Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 73 France Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 74 France Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 75 France Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 76 France Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 77 Italy Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 78 Italy Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 79 Italy Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 80 Italy Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 81 Italy Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 82 Italy Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 83 Italy Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 84 Italy Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 85 Spain Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 86 Spain Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 87 Spain Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 88 Spain Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 89 Spain Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 90 Spain Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 91 Spain Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 92 Spain Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 93 Denmark Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 94 Denmark Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 95 Denmark Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 96 Denmark Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 97 Denmark Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 98 Denmark Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 99 Denmark Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 100 Denmark Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 101 Sweden Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 102 Sweden Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 103 Sweden Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 104 Sweden Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 105 Sweden Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 106 Sweden Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 107 Sweden Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 108 Sweden Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 109 Norway Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 110 Norway Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 111 Norway Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 112 Norway Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 113 Norway Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 114 Norway Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 115 Norway Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 116 Norway Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 117 Asia Pacific Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 118 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 119 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 120 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 121 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 122 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 123 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 124 Asia Pacific Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 125 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 126 Japan Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 127 Japan Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 128 Japan Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 129 Japan Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 130 Japan Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 131 Japan Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 132 Japan Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 133 Japan Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 134 China Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 135 China Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 136 China Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 137 China Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 138 China Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 139 China Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 140 China Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 141 China Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 142 India Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 143 India Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 144 India Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 145 India Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 146 India Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 147 India Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 148 India Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 149 India Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 150 Thailand Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 151 Thailand Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 152 Thailand Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 153 Thailand Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 154 Thailand Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 155 Thailand Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 156 Thailand Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 157 Thailand Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 158 South Korea Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 159 South Korea Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 160 South Korea Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 161 South Korea Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 162 South Korea Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 163 South Korea Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 164 South Korea Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 165 South Korea Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 166 Australia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 167 Australia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 168 Australia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 169 Australia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 170 Australia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 171 Australia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 172 Australia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 173 Australia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 174 Latin America Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 175 Latin America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 176 Latin America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 177 Latin America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 178 Latin America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 179 Latin America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 180 Latin America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 181 Latin America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 182 Latin America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 183 Brazil Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 184 Brazil Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 185 Brazil Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 186 Brazil Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 187 Brazil Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 188 Brazil Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 189 Brazil Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 190 Brazil Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 191 Argentina Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 192 Argentina Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 193 Argentina Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 194 Argentina Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 195 Argentina Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 196 Argentina Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 197 Argentina Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 198 Argentina Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 199 Middle East & Africa Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 200 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 201 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 202 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 203 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 204 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 205 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 206 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 207 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 208 South Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 209 South Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 210 South Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 211 South Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 212 South Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 213 South Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 214 South Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 215 South Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 216 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 217 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 218 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 219 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 220 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 221 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 222 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 223 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 224 UAE Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 225 UAE Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 226 UAE Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 227 UAE Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 228 UAE Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 229 UAE Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 230 UAE Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 231 UAE Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 232 Kuwait Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 233 Kuwait Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 234 Kuwait Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 235 Kuwait Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 236 Kuwait Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 237 Kuwait Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 238 Kuwait Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 239 Kuwait Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 ((USD Million)
  • Table. 240 Financial performance

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Contract Manufacturing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Contract Manufacturing Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Contract Manufacturing Market: Service movement analysis
  • Fig. 21 API manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Finished drug product manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral solids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Liquids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Packaging services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 29 Pharmaceutical Contract Manufacturing Market: Product movement analysis
  • Fig. 30 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Contract Manufacturing Market: Drug outlook and key takeaways
  • Fig. 37 Pharmaceutical Contract Manufacturing Market: Drug movement analysis
  • Fig. 38 Generics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Branded market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Pharmaceutical Contract Manufacturing Market: Scale of operation outlook and key takeaways
  • Fig. 41 Pharmaceutical Contract Manufacturing Market: Scale of operation movement analysis
  • Fig. 42 Batch market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Continuous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical Contract Manufacturing Market: Workflow outlook and key takeaways
  • Fig. 45 Pharmaceutical Contract Manufacturing Market: Workflow movement analysis
  • Fig. 46 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Commercial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Pharmaceutical Contract Manufacturing Market: Application outlook and key takeaways
  • Fig. 49 Pharmaceutical Contract Manufacturing Market: Application movement analysis
  • Fig. 50 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Hormonal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Hematological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Pharmaceutical Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 63 Pharmaceutical Contract Manufacturing Market: End Use movement analysis
  • Fig. 64 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Pharmaceutical Contract Manufacturing Market: Company Size outlook and key takeaways
  • Fig. 67 Pharmaceutical Contract Manufacturing Market: Company Size movement analysis
  • Fig. 68 Small market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Large market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Regional Marketplace: Key Takeaways
  • Fig. 72 North America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 U.S. Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Canada Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Mexico Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Europe Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 UK Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Germany Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 France Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Italy Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Spain Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Asia Pacific Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Japan Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 China Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 India Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Thailand Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 South Korea Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Australia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Latin America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Brazil Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Argentina Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 MEA Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 South Africa Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Fig. Key country dynamics
  • Fig. 118 Saudi Arabia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 UAE Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Kuwait Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Key company categorization
  • Fig. 124 Service heat map analysis
  • Fig. 125 Strategic framework